MedTrace Logo

Modified Surface of PLGA Nanoparticles in Smart Hydrogel

NCT05442736 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2022-07-05

No results posted yet for this study

Summary

Nanoparticles containing antibiotic were prepared and incorporated in in situ gel to treat recurrent endodontic infections

Conditions

  • Antibiotic Resistant Infection

Interventions

DRUG

Ciprofloxacin

studying the effect of nanoparticles in controlling the release of the drug in addition to in situ gel

Sponsors & Collaborators

  • British University In Egypt

    lead OTHER

Principal Investigators

  • Mona Arafa · The British University in Egypt

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-02
Primary Completion
2022-04-16
Completion
2022-04-16

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05442736 on ClinicalTrials.gov